Insiders Myomo, Inc.

Equities

MYO

US62857J2015

Market Closed - Nyse Other stock markets 01:30:00 17/05/2024 am IST			5-day change	1st Jan Change
3.68 ^USD	-2.65%		+3.37%	-26.55%

08/05	Transcript : Myomo, Inc., Q1 2024 Earnings Call, May 08, 2024
08/05	Myomo, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Myomo, Inc. Appoints Heather Getz as Class II Director and Chair of Audit Committee	29/03	CI
Myomo, Inc. Appoints Yitzchak Jacobovitz as A Class II Director	31/23/31	CI
Myomo, Inc. Announces Executive Changes	17/21/17	CI
Myomo, Inc. Appoints Milton Morris as Director	15/21/15	CI
Myomo, Inc. Appoints Harry Kovelman as Chief Medical Officer	02/20/02	CI
Myomo, Inc. Announces Directorate Changes	12/19/12	CI
Myomo, Inc. Elects Steve Sanghi as Class II Director	07/19/07	CI
Myomo, Inc. Announces the Resignation of Davie Mendelsohn as Vice President Business Development, Effective April 12, 2019	04/19/04	CI
Myomo, Inc. Appoints John Frijters as Business Development Manager for EU	12/18/12	CI
Myomo, Inc. Appoints Micah Mitchell as Chief Commercial Officer	09/18/09	CI
Myomo, Inc. Announces Executive Appointments	25/17/25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW